brexit-istock-537519806_andrewlinscott

andrewlinscott / iStockphoto.com

16 August 2019Big PharmaSaman Javed

Pharma bodies sign NDAs with UK govt over no-deal Brexit plans

Several pharma bodies have signed non-disclosure agreements (NDAs) which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

EMA settles Brexit dispute; issues drug shortages guidance

8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

UK faces medicine shortages after no deal: leaked govt report

21 August 2019 A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA

3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.

More on this story

EMA settles Brexit dispute; issues drug shortages guidance

8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

UK faces medicine shortages after no deal: leaked govt report

21 August 2019 A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA

3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.

More on this story

EMA settles Brexit dispute; issues drug shortages guidance

8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

UK faces medicine shortages after no deal: leaked govt report

21 August 2019 A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA

3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB

Lewis Roca promotes tech expert to managing partner

Panitch Schwarze brings in molecular biologist

US targets ‘product hopping’ with biologic litigation curbs

UPC confirms validity of Edwards Lifesciences heart valve tech patent

ITC concludes row over biotech lab equipment between US and German rivals

UKIPO launches ‘revolutionary’ patent filing and AI tool

USPTO clarifies AI's role in patent eligibility